DURHAM, N.C., Oct. 27, 2022 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend lives of patients facing deadly diseases, today announced that it will host a live conference call and audio webcast on Thursday, November 3, 2022 at 8:30 a.m. ET to report financial results for the third quarter ended September 30, 2022, and to provide a business overview.
To access the live conference call, please dial (646) 307-1963 (domestic) or (800) 715-9871 (international) at least five minutes prior to the start time, and refer to conference ID 2765632. A live audio webcast of the call will also be available on the Investors’ section of the Company’s website, www.chimerix.com. An archived webcast will be available on the Chimerix website approximately two hours after the event.
About Chimerix
Chimerix is a biopharmaceutical company with a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The Company’s most advanced clinical-stage development program, ONC201, is in development for H3 K27M-mutant glioma.
CONTACTS:
Michelle LaSpaluto
919 972-7115
ir@chimerix.com
Will O’Connor
Stern Investor Relations
212-362-1200
will@sternir.com
SCOTTSDALE, Ariz., July 3, 2024 /PRNewswire/ -- Evive Brands, a leader in the health and…
CHICAGO, July 3, 2024 /PRNewswire/ -- The global operating room management market is poised to grow…
WESTFORD, Mass., July 3, 2024 /PRNewswire/ -- According to SkyQuest, the global Exoskeleton Market size was…
Business Activity Index at 49.6%; New Orders Index at 47.3%; Employment Index at 46.1%; Supplier…
Codd to Leverage Extensive Background Serving Global Corporations DALLAS, July 3, 2024 /PRNewswire/ -- Axxess,…
French AI company achieves key EU regulatory compliance for multiple algorithms that identify, detect, and…